+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Proton-coupled erythromycin antiport at rat blood-placenta barrier



Proton-coupled erythromycin antiport at rat blood-placenta barrier



Drug Metabolism and Disposition: the Biological Fate of Chemicals 38(9): 1576-1581



The aim of the present study was to characterize the mechanism of erythromycin transport at the blood-placenta barrier, using TR-TBT 18d-1 cells as a model of rat syncytiotrophoblasts. [(14)C]Erythromycin was taken up by TR-TBT 18d-1 cells with a Michaelis constant of 466 microM. Although the uptake was not dependent on extracellular Na(+) or Cl(-), it was increased at weakly alkaline pH. Significant overshoot of [(14)C]erythromycin uptake by placental brush-border membrane vesicles was observed in the presence of an outwardly directed proton gradient. These results indicate that erythromycin is transferred by the H(+)-coupled transport system in syncytiotrophoblasts. To address the physiological transport of erythromycin in rat placenta, fetal-to-maternal transport clearance was estimated by means of the single placental perfusion technique. Clearance of [(14)C]erythromycin was higher than that of [(14)C]inulin, a paracellular pathway marker, and was decreased by the addition of 5 mM erythromycin, indicating that saturable efflux system from fetus to mother is involved. The effect of various transporter inhibitors on [(14)C]erythromycin efflux from TR-TBT 18d-1 cells was evaluated. cyclosporin A, fumitremorgin C, and probenecid had no effect, whereas ethylisopropylamiloride, a specific inhibitor of Na(+)/H(+) exchangers (NHEs), was significantly inhibitory. These results suggest that erythromycin efflux transport at the rat blood-placenta barrier is mediated by an erythromycin/H(+) antiport system, driven by H(+) supplied by NHEs.

(PDF emailed within 0-6 h: $19.90)

Accession: 055260754

Download citation: RISBibTeXText

PMID: 20566696

DOI: 10.1124/dmd.110.033266


Related references

The Transport Mechanisms of Erythromycin in the rat blood placenta barrier. 2007

Evidence for an organic cation-proton antiport system in brush-border membranes isolated from the human term placenta. Journal of Biological Chemistry 263(10): 4561-4568, 1988

Involvement of a proton-coupled organic cation antiporter in the blood-brain barrier transport of amantadine. Biopharmaceutics and Drug Disposition 37(6): 323-335, 2017

Functional regulation of P-glycoprotein at the blood-brain barrier in proton-coupled folate transporter (PCFT) mutant mice. Faseb Journal 27(3): 1167-1175, 2013

Importance of Substrate-Coupled Proton Antiport by the Vesicular Monoamine Transporter in the Actions of Amphetamines in Drosophila Brain. Journal of Alcoholism and Drug Dependence 4(6), 2017

Memantine transport by a proton-coupled organic cation antiporter in hCMEC/D3 cells, an in vitro human blood-brain barrier model. Drug Metabolism and Pharmacokinetics 30(2): 182-187, 2016

Cation/proton antiport systems in Escherichia coli. Solubilization and reconstitution of DpH-driven sodium/proton and calcium/proton antiporters. The Journal of Biological Chemistry 261: 8-83, 1986

Cation/proton antiport systems in Escherichia coli. Solubilization and reconstitution of delta pH-driven sodium/proton and calcium/proton antiporters. Journal of Biological Chemistry 261(2): 678-683, 1986

Intestinal brush-border membrane transport of monocarboxylic acids mediated by proton-coupled transport and anion antiport mechanisms. Journal Of Pharmacy & Pharmacology. 49(1): 108-112, 1997

Involvement of Proton-Coupled Organic Cation Antiporter in Varenicline Transport at Blood-Brain Barrier of Rats and in Human Brain Capillary Endothelial Cells. Journal of Pharmaceutical Sciences 106(9): 2576-2582, 2017

Erythropoietin through the placenta barrier and fetal blood-brain barrier with transient uteroplacental ischemia. Sichuan Da Xue Xue Bao. Yi Xue Ban 43(5): 687-9, 724, 2013

Functional expression of a proton-coupled organic cation (H+/OC) antiporter in human brain capillary endothelial cell line hCMEC/D3, a human blood-brain barrier model. Fluids and Barriers of the Cns 10(1): 8-8, 2013

Proton calcium antiport driven by the pyrophosphate dependent tonoplast proton pump. Experientia 46(ABSTR): A9, 1990

Calcium/proton and sodium/proton antiport systems in Escherichia coli. Journal of Biochemistry 85(4): 943-951, 1979

Cation/proton antiport systems in Escherichia coli. Properties of the calcium/proton antiporter. Journal of Biological Chemistry 254(6): 1957-1963, 1979